-- STOCKS NEWS US-Homebuilding data on tap; builders suffer in 2014
-- 
-- Mon Apr 28, 2014 09:00AM EDT
-- None



April 28 (Reuters) - Monday's economic data calendar is light, with pending home sales for March from the National Association of Realtors the only indicator scheduled <ECONUSTODAY>. The index is expected to rise 1 percent from February's two-plus year low. The report is due at 10 a.m. ET and will keep the underperforming home building group in the spotlight.

The SPDR S&P Homebuilders ETF <XHB.P> is down 6.7 percent year to date vs a gain of just under 1 percent for the S&P 500.From earlier in the day:08:54 - Pfizer <PFE.N> is among the top movers in the early going, up nearly 6 percent at $31.30 in premarket action vs. a $30.75 close.  The Dow component has pitched a takeover offer for British rival AstraZeneca Plc <AZN.L> worth nearly $100 billion and is weighing its next move in the approach after its first two bids were rejected. [ID:nL6N0NK194] AstraZeneca's U.S.-traded shares are up more than 16 percent at nearly $80 in premarket trading.  Pfizer's move follows a spate of deal activity across the health and pharma sector. Last week Zimmer <ZMH.N> agreed to buy Biomet for $13.4 billion, while over the weekend Reuters reported exclusively that Merck <MRK.N> is in talks to sell its consumer unit for nearly $14 billion. [ID:nL3N0NG3TQ][ID:nL6N0NI06U] In the deals-gone-sour department, Newmont Mining <NEM.N> is down close to 6 percent after merger talks with Canada's Barrick Gold <ABX.TO> were terminated. [ID:nL2N0NK0C6] For more on the morning's big movers ahead of the bell click [XHR/US]. On the wider market, index futures' gains are eroding, with the S&P e-minis <ESc1> now up just 3.75 points vs nearly 7 earlier.08:32 - U.S. index futures are all higher Monday morning with more drug-sector M&A activity acting as the main driver. * S&P 500 e-minis <ESc1> are up 6 points, about 0.32 percent, with just under 145,000 contracts traded. * Nasdaq 100s <NDc1> are up 0.27 percent, or 9.75 points, though volume is miniscule at just 79 contracts.